Oxolin (Oxolinum)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspointment nasal
Composition:

In 100 g of ointment is contained active substance: dioxotetrahydroxytetrahydronaphthalene 0.25 g.

Auxiliary substances: paraffin liquid (oil vaseline) - 0.5 g; Vaseline - 99.25 g.

Description:Ointment is light yellow in color. During storage, a pink tint is allowed.
Pharmacotherapeutic group:antiviral agent
Pharmacodynamics:Has antiviral activity, blocking the binding of the influenza virus to the surface of the cell membrane, protects cells from penetrating them virus.
Pharmacokinetics:

- suction: when applied to the mucous membrane, up to 20% of the drug is absorbed. In the body, it is not cumulated and excreted mainly by the kidneys during the day.

Indications:Prevention of influenza, treatment of viral rhinitis
Contraindications:

Individual intolerance of the drug and its components.

Carefully:Child age is up to two years.
Pregnancy and lactation:

The use of the drug during pregnancy and lactation is possible only in case where the intended benefit to the mother exceeds the potential risk for fetus and child.

Dosing and Administration:

Locally. Prevention of influenza: a strip of ointment with a length of 3 to 5 mm smear daily 2-3 times a day in the mucous membrane of the nose during the rise and maximum development of an epidemic outbreak of influenza (for 25 days) or in contact with a sick flu.Treatment of viral rhinitis: a strip of ointment with a length of 3 to 5 mm lubricates the nasal mucosa 2-3 times a day for 3-4 days.

Side effects:When using oksolina ointment in some cases, there is a rapid burning sensation of the nasal mucosa, rhinorrhea.
Overdose:

Cases of drug overdose Oxolin, ointment nasal, are unknown.

Interaction:Interaction with other drugs is not described.
Effect on the ability to drive transp. cf. and fur:

Information on the adverse effects of the drug on the ability to drive vehicles and work with mechanisms is not documented.

Form release / dosage:

Ointment nasal 0,2500%.

Packaging:

By 10,25 or 30 g in tubes are aluminum.

By 5, 10, 15, 20, 25 or 30 g in cans of BTS type orange glass with pull-on lids. The label is self-adhesive on the can. Each tube, together with the instruction for use, is placed in a cardboard package (bundle).

Storage conditions:In a dry, dark place at a temperature of no higher than 10 ° C. ; Keep out of the reach of children.
Shelf life:

2 years. Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe
Registration number:LP-001643
Date of registration:12.04.2012 / 20.04.2017
Expiration Date:Unlimited
The owner of the registration certificate:OZONE, LLC OZONE, LLC Russia
Manufacturer: & nbsp
Information update date: & nbsp12.01.16
Illustrated instructions
    Instructions
    Up